You can now read 10 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe

Business

FDA approves first pre-surgical breast cancer drug

WASHINGTON — The Food and Drug Administration on Monday approved a biotech drug to become the first medicine to treat breast cancer before surgery.

Perjeta, made by Roche’s Genentech unit, would be an option for women with a form of early-stage breast cancer who face a high risk of having their cancer spread. Surgery to remove tumors is usually the first step in treating most forms of cancer.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week